Anticoagulation Management Post Pulmonary Embolism.

Area of Science:

• Cardiology
• Pulmonology
• Pharmacology

Background:

• Pulmonary embolism (PE) presents significant morbidity and mortality risks, particularly in intermediate and high-risk patients.
• Effective anticoagulation management is vital for therapeutic adjustment and patient outcomes.

Purpose of the Study:

• To review primary and long-term anticoagulation management strategies for PE.
• To highlight special patient populations and risk factors influencing anticoagulation choices.

Main Methods:

• Literature review of anticoagulation therapies for PE.
• Analysis of direct oral anticoagulants, Vitamin K antagonists, and low-molecular-weight heparin.
• Focus on special populations including breastfeeding mothers, ESRD, and obese patients.

Main Results:

• Direct oral anticoagulants are the preferred initial anticoagulation choice for PE.
• Vitamin K antagonists and low-molecular-weight heparin are essential for specific patient groups.
• Consideration of patient-specific factors is critical for optimal anticoagulation selection.

Conclusions:

• Anticoagulation management in PE requires careful consideration of initial and long-term strategies.
• Individualized treatment plans are necessary, especially for high-risk patients and special populations.
• Optimizing anticoagulation choice improves outcomes and reduces PE-related complications.